These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 7286056)
1. The pharmacokinetics of trichlormethiazide in hypertensive patients with normal and compromised renal function. Sketris IS; Skoutakis VA; Acchiardo SR; Meyer MC Eur J Clin Pharmacol; 1981; 20(6):453-7. PubMed ID: 7286056 [TBL] [Abstract][Full Text] [Related]
2. Noradrenaline clearance in hypertensive patients with various degrees of renal function. Masuyama Y; Nishimura T; Nishio I; Kuchii M Clin Sci (Lond); 1979 Dec; 57 Suppl 5():213s-215s. PubMed ID: 540434 [TBL] [Abstract][Full Text] [Related]
3. Age-related changes in endocrine and renal function in patients with essential hypertension. Yamada T; Endo T; Ito K; Nagata H; Izumiyama T J Am Geriatr Soc; 1979 Sep; 27(9):398-402. PubMed ID: 469152 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of benazepril in hypertensive patients with normal and impaired renal function. Shionoiri H; Ueda S; Minamisawa K; Minamisawa M; Takasaki I; Sugimoto K; Gotoh E; Ishii M J Cardiovasc Pharmacol; 1992 Sep; 20(3):348-57. PubMed ID: 1279278 [TBL] [Abstract][Full Text] [Related]
5. Pindolol availability in hypertensive patients with normal and impaired renal function. Chau NP; Weiss YA; Safar ME; Lavene DE; Georges DR; Milliez PL Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):505-10. PubMed ID: 913016 [TBL] [Abstract][Full Text] [Related]
6. Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal. Erikson LO; Wåhlin-Boll E; Odar-Cederlöf I; Lindholm L; Melander A Eur J Clin Pharmacol; 1989; 36(2):165-74. PubMed ID: 2721541 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics and hepatic extraction ratio of pindolol in hypertensive patients with normal and impaired renal function. Lavene D; Weiss YA; Safar ME; Loria Y; Agorus N; Georges D; Milliez PL J Clin Pharmacol; 1977; 17(8-9):501-8. PubMed ID: 893736 [TBL] [Abstract][Full Text] [Related]
9. Plasma and urinary catecholamines as related to renal function in man. Laederach K; Weidmann P Kidney Int; 1987 Jan; 31(1):107-11. PubMed ID: 3560639 [TBL] [Abstract][Full Text] [Related]
10. Relationship between plasma concentration and dose of digoxin in patients with and without renal impairment. Okada RD; Hager WD; Graves PE; Mayersohn M; Perrier DG; Marcus FI Circulation; 1978 Dec; 58(6):1196-203. PubMed ID: 709776 [TBL] [Abstract][Full Text] [Related]
11. Influence of chronic renal failure on captopril pharmacokinetics and clinical and biological effects in hypertensive patients. Giudicelli JF; Chaignon M; Richer C; Giroux B; Guedon J Br J Clin Pharmacol; 1984 Nov; 18(5):749-58. PubMed ID: 6095887 [TBL] [Abstract][Full Text] [Related]
12. The effect of renal disease on the pharmacokinetics of diethylcarbamazine in man. Adjepon-Yamoah KK; Edwards G; Breckenridge AM; Orme ML; Ward SA Br J Clin Pharmacol; 1982 Jun; 13(6):829-34. PubMed ID: 7093114 [TBL] [Abstract][Full Text] [Related]
13. Effects of magnesium oxide on trichlormethiazide bioavailability. Takahashi H; Watanabe Y; Shimamura H; Sugito K J Pharm Sci; 1985 Aug; 74(8):862-5. PubMed ID: 4032271 [TBL] [Abstract][Full Text] [Related]
14. Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids. Ferry N; Geoffroy J; Pozet N; Cuisinaud G; Benzoni D; Zech PY; Sassard J Br J Clin Pharmacol; 1988 Mar; 25(3):359-66. PubMed ID: 3358898 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and pharmacodynamics of candesartan cilexetil in patients with normal to severely impaired renal function. Buter H; Navis GY; Woittiez AJ; de Zeeuw D; de Jong PE Eur J Clin Pharmacol; 1999 Feb; 54(12):953-8. PubMed ID: 10192757 [TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function. Aweeka F; Jayesekara D; Horton M; Swan S; Lambrecht L; Wilner KD; Sherwood J; Anziano RJ; Smolarek TA; Turncliff RZ Br J Clin Pharmacol; 2000; 49 Suppl 1(Suppl 1):27S-33S. PubMed ID: 10771451 [TBL] [Abstract][Full Text] [Related]
18. [Effect of renal insufficiency on the pharmacokinetics of captopril and converting enzyme inhibition in the hypertensive patient]. Richer C; Chaignon M; Giroux B; Guédon J; Giudicelli JF Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1216-9. PubMed ID: 6098233 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of nisoldipine in hypertensive patients with normal and mild to moderate impaired renal function. Shionoiri H; Minamisawa K; Masumori S; Satta H; Minamisawa M; Takizawa T; Jinno Y; Takeda K; Nagasawa T; Takasaki I Arzneimittelforschung; 1995 Jul; 45(7):785-9. PubMed ID: 8573223 [TBL] [Abstract][Full Text] [Related]
20. The pharmacology of cefamandole in patients with reduced renal function. Czerwinski AW; Pederson JA Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]